A survey of experts on personalized medicine landscape in European Union and China.

ABSTRACT:

Introduction

Personalized Medicine (PM) is one of the main priorities of the research agenda of the European Commission and the focus of the European Coordination and Support Action titled "Integrating China into the International Consortium for Personalized Medicine" (IC2PerMed). Similar to the European focus, PM is a current priority of the Chinese Government, through dedicated policies and its five-year investment plans. In the context of IC2PerMed, we implemented a survey to understand the state of the art of the implementation of PM related policies in EU and China, and to identify opportunities for future Sino-European collaborations.

Methods

The survey was elaborated by the IC2PerMed consortium and validated by a focus group of experts. The final version, in English a

SUBMITTER: Hoxhaj I 

PROVIDER: S-EPMC10204258 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature